Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Lung AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Lung AI
by Exo

AI Verdict

Tool A focuses on predicting and managing hypotensive events through continuous hemodynamic monitoring, providing early warnings for physiological instability. In contrast, Tool B utilizes AI-powered handheld ultrasound for real-time diagnostic imaging, primarily for lung and cardiac conditions. While both operate in cardiology and emergency medicine, they address distinct clinical needs: one for predictive physiological management and the other for AI-assisted diagnostic visualization.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary concern is the proactive prevention and management of intraoperative or critical care hypotension. This tool is ideal for anesthesiologists and critical care specialists who require continuous, real-time hemodynamic monitoring and predictive analytics to anticipate and intervene before hypotensive events occur, leveraging insights into preload, afterload, and contractility.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Lung AI if…

Choose Lung AI by Exo if you need a portable, AI-powered point-of-care ultrasound solution for rapid diagnosis of lung and cardiac conditions. This tool is best suited for emergency medicine, pulmonology, and critical care professionals who require immediate, on-device AI assistance for detecting conditions like pleural effusion, consolidation/atelectasis, or cardiac abnormalities, enabling quick decision-making in diverse clinical settings.

View Lung AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Lung AI
Pricing Contact-for-pricing Contact for pricing
Deployment Integrated with Edwards Lifesciences HemoSphere Advanced Monitoring Platform (and previously EV1000 Clinical Platform) via dedicated sensors (Acumen IQ cuff or sensor). On-device (integrated with Exo Iris handheld ultrasound device)
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Lung AI

Tool B (Exo Lung AI) emphasizes user-friendliness with features like guided image capture, real-time feedback, and integrated AI-powered education (Exo U). These directly address the learning curve and ease of use for performing and interpreting ultrasound scans, making it accessible to a wider range of clinicians.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A (Acumen HPI) demonstrates significant clinical value by proactively predicting hypotensive events up to 15 minutes in advance and providing insights into their causes. Clinical studies have shown it can significantly reduce the incidence, duration, and severity of intraoperative hypotension, leading to improved patient outcomes such as reduced length of stay and fewer complications.

Pricing & Value

Lung AI

While both require contacting for pricing, Tool B (Exo Lung AI) is a handheld device with on-device AI, and its company's tagline emphasizes 'affordable, easy-to-use medical imaging.' This suggests a strong value proposition for accessibility and potentially lower total cost of ownership compared to Tool A, which is an add-on to a larger critical care monitoring platform requiring dedicated sensors.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A (Acumen HPI) is offered by Edwards Lifesciences, a well-established global medical technology company with deep integration into critical care infrastructure. Its deployment within existing Edwards Lifesciences platforms suggests a mature enterprise-level support and integration model within large hospital systems.

Innovation

Lung AI

Tool B (Exo Lung AI) represents a broader innovation by combining high-performance ultrasound with integrated, on-device AI in a handheld form factor. This democratizes advanced imaging and AI interpretation at the point of care for multiple conditions, including guided image capture and real-time feedback, which is a disruptive approach to traditional imaging workflows.

Support & Docs

Lung AI

Tool B (Exo Lung AI) explicitly lists 'Exo U (AI-powered POCUS education and training)' as a key feature. This integrated educational platform directly addresses user proficiency and ongoing learning, demonstrating a proactive and comprehensive approach to user support and adoption, which is particularly valuable for a point-of-care device.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Lung AI
Name Acumen Hypotension Prediction Index u0096 EV1000 Clinical Platform Lung AI
Company Edwards Lifesciences Exo
Tagline Predicting and managing hypotension before it occurs. Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning.
Primary AI Focus Machine learning to predict hypotensive events Artificial intelligence for imaging and therapeutic applications with ultrasound
Key Predictive/Detection Capability Predicts hypotension up to 15 minutes in advance; HPI Parameter (0-100 likelihood score); Smart Alerts for trending hypotension; Relationship View screen (preload, afterload, contractility insights). AI-powered detection of pleural effusion, consolidation/atelectasis; Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy).
Supported Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Emergency Medicine, Pulmonology

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Lung AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A (Acumen HPI) integrates with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform via dedicated sensors, providing continuous hemodynamic monitoring and predictive insights. Tool B (Lung AI) is integrated with the Exo Iris handheld ultrasound device, with its on-device AI processing. While both aim to streamline data, the specific mechanisms for automated EHR documentation and physician review of AI-generated insights would need further clarification for each system. Exo also offers a cloud-based POCUS workflow and documentation platform that centralizes image storage and automates documentation and QA workflows.
For Tool A (Acumen HPI), internal validation showed that 10 minutes before an event, it predicted hypotension with 89% specificity and 90% sensitivity, and an AUC of 0.95. Other studies have also shown sensitivity and specificity exceeding 80% for predicting hypotensive events up to 15 minutes prior. For Tool B (Lung AI), a multi-reader, multi-case study demonstrated that AI assistance significantly improved sensitivity for pleural effusion (from 77.3% to 89.1%) and consolidation/atelectasis (from 70.7% to 89.2%), with specificity remaining high (91.7% to 92.9% for effusion, 85.8% to 89.5% for consolidation). Another study reported ExoLungAI achieved 91% sensitivity and 81% specificity for A-line detection, and 84% sensitivity and 86% specificity for B-line detection.
Tool A (Acumen HPI) involves interpreting an HPI parameter (0-100 score) and related hemodynamic insights, with Edwards Lifesciences providing clinical education and resources to support learning. Tool B (Lung AI) is designed to be easy-to-use with features like guided image capture and 'Exo U' for AI-powered POCUS education and training, which helps clinicians of varying expertise levels improve diagnostic performance.
Tool A (Acumen HPI) offers significant value in surgical and critical care settings, particularly for anesthesiology and emergency medicine, by predicting intraoperative hypotension up to 15 minutes in advance and providing insights into its root causes. Tool B (Lung AI) is highly valuable in point-of-care settings, including emergency medicine, cardiology, and pulmonology, enabling real-time detection of conditions like pleural effusion, consolidation/atelectasis, and automated indicators for cardiac conditions such as heart failure, especially in underserved or rural areas.
While the provided information does not explicitly detail audit-trail capabilities for either tool, robust audit controls are a general requirement for AI systems handling Protected Health Information (PHI) to ensure data integrity, accountability, and compliance with healthcare regulations.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Lung AI

AI Tool Finder
AI-powered search. Results may not be comprehensive.